ABT

Abbott Laboratories
D

ABT

93.850
USD
0.62
(0.67%)
Post Trading·93.950USD+0.100(+0.11%)
Volume
376,734
EPS
5
Div Yield
2.78
P/E
26
Market Cap
163,469,164,503
OverviewSignalsNews
Signals
هشام منسي
هشام منسي
7 months ago
buy
ABT
ABT @125.84
2025-11-05 05:42
ABT@125.84 Chart
Profit
148.00
2.35%
More
Related Instruments
BAX
BAX
D
22.040
0.490(2.27%)
BDX
BDX
D
155.895
4.515(2.98%)
BSX
BSX
D
44.140
-0.065(-0.15%)
44.110-0.030(-0.07%)
DHR
DHR
D
195.740
2.420(1.25%)
195.7400.000(0.00%)
JNJ
JNJ
D
254.340
9.360(3.82%)
254.580+0.240(+0.09%)
MDT
MDT
D
80.964
0.494(0.61%)
80.970+0.006(+0.01%)
SYK
SYK
D
332.85
16.74(5.30%)
TMO
TMO
D
513.15
7.23(1.43%)
511.50-1.65(-0.32%)
WAT
WAT
D
374.21
-2.69(-0.71%)
More
News
ArincenArincen
XAUUSD
BTCUSD
OILUSD
INTC
META
ABT
MKC
GE
5 months ago

The US Dollar Loses Momentum Against Major Currencies Amid Potential Foreign Exchange Market Moves

ArincenArincen
XAUUSD
BTCUSD
OILUSD
EURUSDEURUSD
USDJPYUSDJPY
GBPUSDGBPUSD
USDCADUSDCAD
NZDUSDNZDUSD
5 months ago

Market Summary: What Happened Yesterday and What Awaits us Today (January 23)

More

Title: Abbott Laboratories

Sector: Healthcare
Industry: Medical Devices
Abbott Laboratories is an American multinational healthcare company that develops, manufactures and markets a diversified line of healthcare products and services. Headquartered in Abbott Park, Illinois, the company was founded by physician Wallace Calvin Abbott in 1888. In 2013, the company split off its research division, AbbVie, leaving it to operate as an independent entity. Among its best-known products in medical devices, diagnostics and nutrition products are Pedialyte, Similac, Ensure, Glucerna, FreeStyle Libre, i-STAT and MitraClip.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.